Steve E. Krognes Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steve E. Krognes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steve E. Krognes. Steve E. Krognes is a Director in Corvus Pharmaceuticals, Inc. ($CRVS) and a CFO and Treasurer in Denali Therapeutics Inc. ($DNLI) and a Director in Gritstone Oncology, Inc. ($GRTS).
Address: C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME 94010 CA
Companies in which Steve E. Krognes is an Insider
Corvus Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steve E. Krognes: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2020
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Denali Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steve E. Krognes: CFO and Treasurer
Holdings: 886,742 shares
Latest Transaction: Mar 16 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gritstone bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steve E. Krognes: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Steve E. Krognes
Sentiment: All, CRVS, DNLI, GRTS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 63.67 | 1,158 | 73,730 | 850,000 | 851.2 K to 850 K (-0.14 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.71 | 3,258 | 204,319 | 851,158 | 854.4 K to 851.2 K (-0.38 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.04 | 32,326 | 2,005,602 | 854,416 | 886.7 K to 854.4 K (-3.65 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 61.16 | 13,258 | 810,912 | 886,742 | 900 K to 886.7 K (-1.47 %) |
| Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 71.43 | 400 | 28,571 | 97,587 | 98 K to 97.6 K (-0.41 %) |
| Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.17 | 2,635 | 184,908 | 97,987 | 100.6 K to 98 K (-2.62 %) |
| Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 4,250 | 0 | 8,500 |